Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.50 (7.143%)
Open: 7.25
High: 7.25
Low: 7.25
Prev. Close: 7.25
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Oct 2008 09:37

2 October 2008 Totally plc (`'Totally'' or `'the Company'') Issue of warrants

In the announcement made on 1 September 2008 relating to the disposal of a trading subsidiary, the Company announced that The Zvhil-Mezbuz Rebbe, Grand Rabbi Y.A. Korff of Boston ("the Rebbe") would be released from his obligations under the guarantee to Bank Hapoalim to support the Company's banking facility. The guarantee to Bank Hapoalim to support the extended credit facility of ⣠700,000 for the Company would be provided by Leo Noĩ, a third party shareholder, and Dr Michael Sinclair, Non-Executive Chairman (together the "Guarantors").

In addition, the Company stated that it was the intention of the Board to issue warrants to Leo Noĩ and Dr Sinclair as guarantors of the facility in the near future in recognition of the increase in their personal guarantees.

Following approval of the resolutions at the general meeting of the Company held on 25 September 2008 and in accordance with the terms of the Jewish Advocate Publishing Corporation share purchase agreement, the Company has today cancelled warrants to subscribe for 4,394,350 ordinary shares which had been issued to the Rebbe.

Furthermore, owing to the exercise price of all of the warrants previously issued in relation to the personal guarantees to Bank Hapoalim to support the Company's overdraft facility being significantly above the current share price, the Company has agreed to cancel all the warrants issued to Dr Sinclair and Leo Noĩ and to replace the cancelled warrants, by issuing 35,000,000 warrants to each of Dr Sinclair and Leo Noĩ in recognition of the fact that the Guarantors have continued to provide personal guarantees to Bank Hapoalim.

The warrants are exercisable immediately from the date of issue for a period of five years at an exercise price of 1 penny per share, being the nominal value of the Company's ordinary shares, which is a premium of 132.5 per cent over the closing middle-market price on 1 October 2008.

At the date of this announcement, Dr Sinclair holds 14,509,791 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share. Mr Noĩ currently holds 6,666,666 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share.

Following the issue of the new warrants detailed above there will be warrants outstanding over 90,123,013 Ordinary Shares, equivalent to 98.02 per cent. of the issued voting share capital of the Company, which are exercisable at exercise prices ranging from 1 to 5 pence per share.

At the date of this announcement the Company has 91,947,934 ordinary voting shares in issue.

If Dr Sinclair were to exercise his warrants and no other shares in the Company were to be issued, Dr Sinclair would hold 49,509,791 ordinary shares, representing 39.00 per cent. of the then enlarged issued share capital. If Leo Noĩ were to exercise his warrants and no other shares in the Company were issued, Mr Noĩ would hold 41,666,666 ordinary shares, equivalent to 32.82 per cent. of the then enlarged issued share capital. In addition, if both Dr Sinclair and Mr Noĩ were to exercise their warrants and no other shares in the Company be issued, between them they would hold 91,176,457 ordinary shares, equivalent to 56.30 per cent. of the then enlarged issued share capital.

Were either of Dr Sinclair or Mr Noĩ to exercise their warrants, to such an extent that individually they would hold 30 per cent. or more of the then issued share capital, they would first need to be granted a waiver of Rule 9 of the Takeover Code, which would need to be approved by shareholders of the Company at a general meeting.

Under the AIM Rules, the issue of the warrants is classified as a related party transaction. The directors, other than Dr Michael Sinclair, who is interested in the warrant issue, (the "Independent Directors") who have consulted with John East & Partners Limited, consider the terms of the warrant issue to be fair and reasonable insofar as the shareholders are concerned. In advising the Independent Directors, John East & Partners Limited has relied upon their commercial assessment.

For further information:

Totally Plc www.totallyplc.com T: 020 7692 6929

Daniel Assor CEO John East & Partners Limited T: 020 7628 2200

David Worlidge / Simon Clements HB Corporate T: 020 7510 8654

Luke Cairns

vendor
Date   Source Headline
16th May 20244:49 pmRNSHolding(s) in Company
13th May 20242:15 pmRNSHolding(s) in Company
13th May 202411:30 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.